Home >> Tag Archives: Fluxion Biosciences—

Tag Archives: Fluxion Biosciences—

Fluxion, Swift jointly develop NGS workflow, 9/15

Fluxion Biosciences and Swift Biosciences announced a jointly developed workflow for oncology clinical research designed to detect somatic mutations from a routine blood draw. The workflow uses Fluxion’s IsoFlux System for circulating tumor cell enrichment and Swift’s Accel-Amplicon technology for high-sensitivity variant detection using low starting inputs.

Read More »